Literature DB >> 29969910

Impulsivity predicts illness severity in long-term course of bipolar disorder: A prospective approach.

Jonas Rote1,2, Alice-Mai-Ly Dingelstadt1,2, Annette Aigner3, Michael Bauer2, Jana Fiebig1,4, Barbara König5, Johanna Kunze6, Steffi Pfeiffer2, Andrea Pfennig2, Esther Quinlivan1, Christian Simhandl7,8, Thomas J Stamm1,4.   

Abstract

BACKGROUND: Bipolar disorder is a common, severe and chronic mental illness. Despite this, predictors of illness severity remain poorly understood. Impulsivity is reported to be associated with bipolar disorder and aggravating comorbidities. This study therefore sought to examine the predictive value of impulsivity for determining illness severity in euthymic bipolar disorder patients.
METHODS: Baseline trait impulsivity of 120 bipolar euthymic patients (81 bipolar disorder I [68%], 80 female [67%]) and 51 healthy controls was assessed using Barratt Impulsiveness Scale 11. The impact of impulsivity on illness severity (measured with morbidity index) was prospectively tested in 97 patients with sufficient follow-up data (average observation time: 54.4 weeks), using linear regression analysis.
RESULTS: Barratt Impulsiveness Scale 11 total (β = 0.01; p < 0.01) and in particular Barratt Impulsiveness Scale 11 attentional subscale scores (β = 0.04; p < 0.001) predicted illness severity in bipolar disorder, while controlling for other clinical variables. Only age at onset persisted as an additional, but less influential predictor. Barratt Impulsiveness Scale 11 total scores and Barratt Impulsiveness Scale 11 attentional subscale scores were significantly higher in euthymic patients compared to controls. This was not observed for the motor or non-planning subscale scores. LIMITATIONS: The average year-long observation time might not be long enough to account for the chronic course of bipolar disorder.
CONCLUSION: Trait impulsivity and particularly attentional impulsivity in euthymic bipolar patients can be strong predictors of illness severity in bipolar disorder. Future studies should explore impulsivity as a risk assessment for morbidity and as a therapeutic target in bipolar disorder patients.

Entities:  

Keywords:  Bipolar disorder; impulsivity; morbidity

Mesh:

Year:  2018        PMID: 29969910     DOI: 10.1177/0004867418783062

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  4 in total

1.  Impulsivity, Unplanned Pregnancies, and Contraception Among Women with Bipolar Disorder.

Authors:  Meliha Zengin Eroglu; Melek Gözde Lus
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-07       Impact factor: 2.570

2.  White Matter Correlates of Early-Onset Bipolar Illness and Predictors of One-Year Recurrence of Depression in Adults with Bipolar Disorder.

Authors:  João Paulo Lima Santos; Michele Bertocci; Genna Bebko; Tina Goldstein; Tae Kim; Satish Iyengar; Lisa Bonar; MaryKay Gill; John Merranko; Anastasia Yendiki; Boris Birmaher; Mary L Phillips; Amelia Versace
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

3.  The big five model in bipolar disorder: a latent profile analysis and its impact on longterm illness severity.

Authors:  Niklas Ortelbach; Jonas Rote; Alice Mai Ly Dingelstadt; Anna Stolzenburg; Cornelia Koenig; Grace O'Malley; Esther Quinlivan; Jana Fiebig; Steffi Pfeiffer; Barbara König; Christian Simhandl; Michael Bauer; Andrea Pfennig; Thomas J Stamm
Journal:  Int J Bipolar Disord       Date:  2022-01-18

4.  The Influence of 5-HTTLPR, BDNF Rs6265 and COMT Rs4680 Polymorphisms on Impulsivity in Bipolar Disorder: The Role of Gender.

Authors:  Andrea Boscutti; Alessandro Pigoni; Giuseppe Delvecchio; Matteo Lazzaretti; Gian Mario Mandolini; Paolo Girardi; Adele Ferro; Michela Sala; Vera Abbiati; Marco Cappucciati; Marcella Bellani; Cinzia Perlini; Maria Gloria Rossetti; Matteo Balestrieri; Giuseppe Damante; Carolina Bonivento; Roberta Rossi; Livio Finos; Alessandro Serretti; Paolo Brambilla
Journal:  Genes (Basel)       Date:  2022-03-09       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.